The DJS Law Group reminded investors of a class action lawsuit against ADMA Biologics (NASDAQ: ADMA) alleging violations of §§10(b) and 20(a) of the Securities Exchange Act and Rule 10b-5. The filing is a negative legal overhang, though the update provides no quantified financial impact or resolution terms.
The DJS Law Group reminded investors of a class action lawsuit against ADMA Biologics (NASDAQ: ADMA) alleging violations of §§10(b) and 20(a) of the Securities Exchange Act and Rule 10b-5. The filing is a negative legal overhang, though the update provides no quantified financial impact or resolution terms.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly negative
Sentiment Score
-0.25
Ticker Sentiment
